Glenn D. Steele's most recent trade in PTC Therapeutics Inc was a trade of 12,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Glenn D. Steele | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Sale of securities on an exchange or to another person at price $ 76.35 per share. | 02 Jan 2026 | 12,000 | 18,500 (0%) | 0% | 76.4 | 916,200 | Common Stock |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 02 Jan 2026 | 12,000 | 30,500 (0%) | 0% | 30.9 | 370,320 | Common Stock |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 4,000 | 22,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,475 | 3,475 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 18,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | D. Glenn Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 14,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 10,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 6,500 (0%) | 0% | 0 | Common Stock |